Ascertaining prognosis for breast cancer in node-negative patients with innovative survival analysis

Breast Journal

Volumn 12, Issue 1, 2006, Pages 37-47

  Chapman, Judith Anne W ^a,c,g   Lickley, H Lavina A ^b,c   Trudeau, Maureen E ^b,d   Hanna, Wedad M ^b,c   Kahn, Harriette J ^b,c   Murray, David ^b,e   Sawka, Carol A ^b,d   Mobbs, Betty G ^b   McCready, David R ^b,f   Pritchard, Kathleen I ^b,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^e ST MICHAEL'S HOSPITAL   (Canada)

^f UNIVERSITY HEALTH NETWORK   (Canada)

^g QUEEN S UNIVERSITY   (Canada)

Author keywords

Breast cancer; Node negative; Prognosis

Indexed keywords

DNA; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGE; ARTICLE; BODY WEIGHT; BREAST CANCER; CANADA; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER INVASION; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CELL CYCLE S PHASE; COHORT ANALYSIS; DISEASE FREE INTERVAL; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; PLOIDY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; QUANTITATIVE ANALYSIS; SURVIVAL RATE; SURVIVAL TIME; TUMOR VOLUME;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; DECISION SUPPORT TECHNIQUES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; ONTARIO; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 33644925322     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1075-122X.2006.00183.x     Document Type: Article

References (40)

1. Henderson IC Patek AJ The relationship between prognostic and predictive factors in the management of breast cancer Breast Cancer Res Treat 1998 52 261 88
2. Isaacs C Stearns V Hayes DF New prognostic factors for breast cancer recurrence Semin Oncol 2001 28 5367
3. Altman DG Lausen B Sauerbrei W Schumacher M Dangers of using "optimal" cutpoints in the evaluation of prognostic factors J Natl Cancer Inst 1994 86 829 35
4. Chapman JW Mobbs BG Hanna WM et al. The standardization of estrogen receptors J Steroid Biochem Mol Biol 1993 45 367 73
5. Chapman JW Wolman E Wolman SR et al. Assessing genetic markers of tumour progression in the context of intratumour heterogeneity Cytometry 1998 31 67 73
6. Chapman JW Mobbs BG Hanna W et al. A changing role for steroid hormone receptors in primary breast cancer? Curr Topics Steroid Res 2000 3 39 51
7. Allred DC Harvey JM Berardo M Clark GM Prognostic and predictive factors in breast cancer by immunohistochemical analysis Mod Pathol 1998 11 155 68
8. Lawless JF Singhal K Efficient screening of non-normal regression models Biometrics 1978 34 318 27
9. Lawless JF Singhal K ISMOD: an all-subsets regression program for generalized linear models. II. Program guide and examples Comput Methods Programs Biomed 1987 24 125 34
10. Kuk AYC All subsets regression in a proportional hazards model Biometrika 1984 71 587 92
11. Hanna WM Kahn HJ Chapman JW Fish EB Lickley HLA McCready DR Pathologic characteristics of breast cancer that predict for local recurrence after lumpectomy alone Breast J 1999 5 105 11
12. Struthers CA Kalbfleisch JD Misspecified proportional hazard models Biometrika 1986 73 363 69
13. Anderson GL Fleming TR Model misspecification in proportional hazards regression Biometrika 1995 82 527 41
14. Gerds TA Schumaker M On functional misspecification of covariates in the Cox regression model Biometrika 2001 88 572 80
15. McCready DR Chapman JW Hanna WM et al. Factors affecting distant disease-free survival for primary invasive breast cancer: use of a log-normal survival model Ann Surg Oncol 2000 7 416 26
16. He W Lawless JF Bivariate location-scale models for regression analysis, with applications to lifetime data J R Stat Soc B 2005 67 63 78
17. Royston P The lognormal distribution as a model for survival time in cancer, with an emphasis on prognostic factors Stat Neerlandica 2001 55 89 104
18. Trudeau ME Pritchard KI Chapman JW et al. Prognostic factors affecting the natural history of node-negative breast cancer Breast Cancer Res Treat 2005 89 35 45
19. Sawka CA Pritchard KI Lickley HLA et al. The Henrietta Banting Breast Centre Database: a model for clinical research utilizing a hospital-based inception cohort J Clin Epidemiol 1995 48 779 86
20. Chapman JW Murray D McCready DR et al. An improved statistical approach: can it clarify the role of new prognostic factors for breast cancer? Eur J Cancer 1996 32 1949 56
21. Ravdin PM Siminoff LA Davis GJ et al. Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer J Clin Oncol 2001 19 980 91
22. Fish EB Chapman JW Link MA Competing causes of death for primary breast cancer Ann Surg Oncol 1998 5 368 75
23. Meakin JW Hayward JL Stewart HJ Assessment of response and recurrence in breast cancer Semin Oncol 1978 5 445 49
24. Kalbfleisch JD Prentice RL The Statistical Analysis of Failure Time Data New York John Wiley & Sons 1980 21 35
25. Hedley DW Clark GM Cornelisse CJ Killander D Kute T Merkel D Consensus review of the utility of DNA cytometry in carcinoma of the breast Breast Cancer Res Treat 1993 28 55 59
26. BMDP Statistical Software, PC Dynamic 7.0. Saugua, MA Statistical Solutions Ltd. 1993
27. Loprinzi CL Thomé SD Understanding the utility of adjuvant systemic therapy for primary breast cancer J Clin Oncol 2001 19 972 79
28. Boag JW Maximum likelihood estimates of the proportion of patients cured by cancer therapy J R Stat Soc B 1949 11 15 44
29. Berg JW The distribution of cancer deaths in time: a survey test of the lognormal model Br J Cancer 1965 19 695 711
30. Hibberd AD Horwood LJ Wells JE Long term prognosis of women with breast cancer in New Zealand: study of survival to 30 years Br Med J 1983 286 1777 79
31. Rutqvist LE Wallgren A Nilsson BO Is breast cancer a curable disease? Cancer 1984 53 1793 800
32. Chapman JW Trudeau ME Pritchard KI et al. A comparison of all subset Cox and accelerated failure time models with Cox step-wise regression for node positive breast cancer Breast Cancer Res Treat 1992 22 263 72
33. Gamel JW Vogel RL McLean IW Assessing the impact of adjuvant therapy on cure rate for stage 2 breast carcinoma Br J Cancer 1993 68 115 18
34. Gamel JW Vogel RL A model of long-term survival following adjuvant therapy for stage 2 breast cancer Br J Cancer 1993 68 1167 70
35. Veronesi U Marubini E Del Vecchio M et al. Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events J Natl Cancer Inst 1995 87 19 27
36. Saphner T Tormey DC Gray R Annual hazard rates of recurrence for breast cancer after primary therapy J Clin Oncol 1996 14 2738 46
37. Heimann R Hellman S Clinical progression of breast cancer malignant behavior: what to expect and when to expect it J Clin Oncol 2000 18 591 99
38. Sun J Chapman J Gordon R Sivaramakrishna R Link M Fish E Survival from primary breast cancer after routine clinical use of mammography Breast J 2002 8 199 208
39. Tai P Yu E Skarsgard D Tonita J Validation of the lognormal model for prediction of long-term survival rates from short-term follow-up data in stages III and IV breast cancer: a 22-year follow-up study Curr Oncol 2003 10 191 94
40. van't Veer LJ Dai H van de Vijver MJ et al. Gene expression profiling predicts clinical outcome of breast cancer Nature 2002 415 530 36